Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock
Abbott Laboratories (NYSE:ABT) is one of the Best Blue Chip Stocks Under $100 to Buy Now. On May 27, analyst David Roman from Goldman Sachs maintained a “Buy” rating on the company’s stock and reduced the price objective to $113.00 from $121.00 The analyst’s rating